Literature DB >> 9576184

The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children.

M D Carcao1, V S Blanchette, J A Dean, L He, M A Kern, A M Stain, C R Sparling, D Stephens, G Ryan, J Freedman, M L Rand.   

Abstract

The PFA-100 system provides an in-vitro method of assessing primary platelet-related haemostasis by measuring the time (the closure time, or CT) taken for a platelet plug to occlude a microscopic aperture cut into a membrane coated with collagen and either epinephrine or ADP. We used the system to establish normal ranges for CTs in healthy children, adults and neonates. Mean CTs of healthy children were independent of the needle gauge used (21G or 23CG) for blood sampling; they were very similar to the mean CTs of healthy adults, but longer than mean CTs of healthy neonates. Although children with haemophilia had normal CTs, the PFA-100 system was found to be potentially useful in screening for von Willebrand disease in children.

Entities:  

Mesh:

Year:  1998        PMID: 9576184     DOI: 10.1046/j.1365-2141.1998.00656.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease.

Authors:  A J Peters; M Borries; F Gradaus; T W Jax; F C Schoebel; B E Strauer
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Migration distance-based platelet function analysis in a microfluidic system.

Authors:  Suk-Heung Song; Chae-Seung Lim; Sehyun Shin
Journal:  Biomicrofluidics       Date:  2013-11-04       Impact factor: 2.800

4.  Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes.

Authors:  Markus Schmugge; Oliver Speer; Sabine Kroiss; Walter Knirsch; Oliver Kretschmar; Margaret L Rand; Manuela Albisetti
Journal:  Eur J Pediatr       Date:  2015-01-16       Impact factor: 3.183

Review 5.  Antiplatelet therapy in pediatric cardiovascular patients.

Authors:  Jennifer S Li; Jane W Newburger
Journal:  Pediatr Cardiol       Date:  2010-03-06       Impact factor: 1.655

Review 6.  An approach to the diagnosis and treatment of bleeding disorders in infants.

Authors:  Thomas C Abshire
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 7.  Antithrombotic drug treatment of pediatric patients with ischemic stroke.

Authors:  Ulrike Nowak-Göttl; Ronald Sträeter; Guillaume Sébire; Fenella Kirkham
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 8.  Neonatal platelet physiology and implications for transfusion.

Authors:  Francisca Ferrer-Marín; Martha Sola-Visner
Journal:  Platelets       Date:  2021-08-16       Impact factor: 3.862

9.  The approach to a patient with a bleeding disorder: for the primary care physician.

Authors:  Layla A M Bashawri; Mirghani A Ahmed
Journal:  J Family Community Med       Date:  2007-05

Review 10.  Hemostatic Testing in Critically Ill Infants and Children.

Authors:  Alison B Nair; Robert I Parker
Journal:  Front Pediatr       Date:  2021-01-08       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.